Latest Content

Novel Drug Combo Doubles Progression-Free Survival in HER2-Negative Metastatic Breast Cancer

December 7th 2021, 10:00pm

By Jessica Hergert


Ibrance plus Faslodex improved progression-free survival in certain patients with metastatic breast cancer, compared with those who continued to receive an aromatase inhibitor.

Geriatric Assessments May Open the Door to High-Quality Conversations About Frailty and Aging-Related Concerns in Older Patients With Advanced Cancer

December 7th 2021, 8:00pm

By Darlene Dobkowski, MA


Frail patients older than 70 years who underwent geriatric assessment and received pertinent advice related to those results were more likely to have high-quality conversations with their oncologists about age-related concerns like physical activity and cognition.

Why I View the Cancer Treatment-Related Changes of My Body With Humor

December 7th 2021, 6:00pm

By Julie S. Brokaw


An ovarian cancer survivor describes the changes her body endured after treatment and explains why she chooses to laugh at them.

Black Women With Breast Cancer Have a Higher Risk of Developing Lymphedema Than White Women

December 7th 2021, 4:00pm

By Ryan McDonald


Black race is associated with a 3.5-fold increased incidence of lymphedema in women with breast cancer treated with axillary lymph node dissection and radiotherapy, according to recent data.

CURE® Honors Patients, Advocates, Oncologist in Inaugural Metastatic Breast Cancer Heroes™ Award Program for Increasing Awareness

December 7th 2021, 2:00pm

By Darlene Dobkowski, MA


CURE’s Metastatic Breast Cancer Heroes™ Award Program expresses gratitude to the heroes who impact the lives of patients with metastatic breast cancer.

CURE Remembers MJH Life Sciences Founder Michael J. Hennessy

December 6th 2021, 10:00pm

By Kristie L. Kahl


Hennessy, 61, founded MJH Life Sciences, the publisher of CURE Magazine, more than 20 years ago.

Combination Immunotherapy Helps Patients With Kidney Cancer Live Longer and ‘Get Back to Their Regular Lives’

December 6th 2021, 8:00pm

By Colleen Moretti


Survival with Opdivo and Yervoy was more than twice as long when compared with Sutent alone in patients with kidney cancer.

What A Mother of a Cancer Survivor Really Wants for Christmas

December 6th 2021, 6:00pm

By Debbie Legault


A mother of a young breast cancer survivor shares the letter she wrote to Santa explaining her only Christmas wish.

The Ins and Outs of Risk Stratification, Managing Side Effects and Survivorship in Breast Cancer

December 6th 2021, 4:00pm

By Colleen Moretti


Patients who understand their roles and responsibilities may better help their care teams understand what they may be at risk for in their cancer survivorship.

Prior Successful Coping Strategies May Help Manage Cancer-Related Stress

December 6th 2021, 2:00pm

By Jamie Cesanek


People who have successfully navigated difficult times in the past may be able to use those previous coping strategies to help them weather new stress related to a cancer diagnosis, treatment or survivorship, according to an expert from the George Washington University Cancer Center.

The Multi-Billion-Dollar Business Behind Cancer: Why Is it a Commodity?

December 5th 2021, 4:00pm

By Khevin Barnes


A male breast cancer survivor takes a critical look at the confusing marketing campaigns that surround his disease.

My Dear Friend and Cancer ‘Warrior’ Refuses to Fold

December 5th 2021, 3:00pm

By Myli Vanegas


A cancer survivor describes an inspiring close friend who has been dealing with cancer for 13 years and refuses to give up.

Why a Piece of Paper Is a Cancer Survivor’s Most Prized Possession

December 4th 2021, 4:00pm

By Laura Yeager


A cancer survivor explains how her most prized possession went from being a faux fur coat to the slip of paper that reads, “No cancer detected.”

The Superhero Oncologist Who Saved My Friend From Cancer

December 4th 2021, 3:00pm

By Carla Melander


A woman explains how her close friend achieved remission from stage 4 lung cancer after being treated by Dr. Bret Friday – a superhero in her book.

FDA Approves Adjuvant Keytruda for Pediatric and Adult Melanoma

December 4th 2021, 12:13am

By Brielle Benyon


The FDA approved adjuvant Keytruda for patients ages 12 and older with stage 2b, 2c or 3 melanoma that has been completely resected.